Entera Bio Ltd (ENTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Entera Bio Ltd (ENTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8178
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that provides development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical ingredients. It conducts clinical trials of three candidate drugs based on applying Entera’s technology to teriparatide for the treatment of hypoparathyroidism, osteoporosis, bone healing, and others. The company also provides clinical trial programs and orphan drug designation for hypoparathyroidism. Entera Bio is headquartered in Jerusalem, Israel.

Entera Bio Ltd (ENTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Equity Offering 12
Entera Bio Raises USD11 Million in IPO of Shares 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 13
Entera Bio Ltd – Key Competitors 14
Entera Bio Ltd – Key Employees 15
Entera Bio Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Entera Bio Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Entera Bio Raises USD2 Million in Venture Financing 10
Entera Bio Plans to Raise USD10 Million in Venture Financing 11
Entera Bio Raises USD11 Million in IPO of Shares 12
Entera Files Registration Statement to Raise Funds through Public Offering of Shares 13
Entera Bio Ltd, Key Competitors 14
Entera Bio Ltd, Key Employees 15

List of Figures
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Entera Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Entera Bio Ltd (ENTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with …
  • Gard P & I (Bermuda) Ltd.:企業の戦略・SWOT・財務分析
    Gard P & I (Bermuda) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Gard P & I (Bermuda) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dynasty Fine Wine Group Limited:企業の戦略・SWOT・財務分析
    Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report Summary Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Trivitron Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Russian Standard Bank:企業の戦略・SWOT・財務情報
    Russian Standard Bank - Strategy, SWOT and Corporate Finance Report Summary Russian Standard Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Abu Dhabi Commercial Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Nido Petroleum Ltd:企業の戦略的SWOT分析
    Nido Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Texas Roadhouse Inc (TXRH):企業の財務・戦略的SWOT分析
    Texas Roadhouse Inc (TXRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Owensboro Municipal Utilities:企業の発電所・SWOT分析2018
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Hawaii Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hawaii Biotech Inc (Hawaii Biotech) is a biotechnology company that offers research and development of vaccines for established and emerging infectious diseases. The company's products include west nile virus vaccine, tick-borne flavivirus vaccine, malaria vaccine, and recombinant protein ex …
  • Navid Zar Chimi Ind Co:企業の戦略的SWOT分析
    Navid Zar Chimi Ind Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • International Paper APPM Limited:企業の戦略・SWOT・財務情報
    International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report Summary International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • YRC Worldwide Inc.:企業の戦略・SWOT・財務情報
    YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report Summary YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Symbolic Displays Inc:企業の戦略・SWOT・財務情報
    Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ABC Supply Co. Inc.:企業の戦略・SWOT・財務情報
    ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆